KRAS was long thought undruggable in cancer until scientists discovered a hidden binding pocket in mutant KRAS, leading to targeted therapies.
Asfar S. Azmi
Advertisement
Associate professor of oncology at Roswell Park Comprehensive Cancer Center.
Articles by Asfar S. Azmi
Advertisement
Latest Updated Articles
KRAS Cancer Drugs Explained: How KRAS Became a Drug TargetApril 29th 2026
Advertisement
Advertisement
Trending on CURE
1
Top 5 Takeaways From EHA 2026 That Patients Should Know
2
An Oncology Physical Therapist Explains Why Movement Matters Most During Cancer Treatment
3
Of Course I Worry: Living With Uncertainty Six Years After Remission
4
When a Routine Cancer Screening Stops Being Routine
5